文献速递流行病学与生物统计

有利结果和公共资助的研究更可能发表:一项系统综述与荟萃分析

Favorable and publicly funded studies are more likely to be published: a systematic review and meta-analysis.
PubMed 文献 · J Clin Epidemiol · 2017-08-31

该研究检索追踪临床研究从启动到发表过程的队列文献,纳入85个研究队列,采用随机效应模型进行传统荟萃分析与荟萃回归。结果显示,有利结果(OR=2.04;95%CI:1.62,2.57)、统计学显著结果(OR=2.07;95%CI:1.52,2.81)、多中心设计(OR=1.32;95%CI:1.16,1.45)及较晚监管分期(3/4期 vs. 1/2期,OR=1.34;95%CI:1.14,1.49)与发表概率显著升高相关;产业资助与发表概率轻度降低相关(OR=0.81;95%CI:0.67,0.99)。

要点

  • 有利结果的研究发表概率更高(OR=2.04;95%CI:1.62,2.57)。
  • 统计学显著结果的研究发表概率更高(OR=2.07;95%CI:1.52,2.81)。
  • 产业资助与发表概率轻度降低相关(OR=0.81;95%CI:0.67,0.99)。

核心结论

  • 研究特征为有利结果和统计学显著结果与更高的发表概率相关。

研究设计与样本

  • 系统综述与荟萃分析,检索追踪临床研究队列从启动到发表过程的文献,最终纳入85个研究队列。

主要发现

  • 有利结果的研究发表概率显著更高(OR=2.04;95%CI:1.62,2.57)。
  • 统计学显著结果的研究发表概率显著更高(OR=2.07;95%CI:1.52,2.81)。
  • 多中心设计的研究发表概率显著更高(OR=1.32;95%CI:1.16,1.45)。
  • 较晚监管分期(3/4期 vs. 1/2期)的研究发表概率显著更高(OR=1.34;95%CI:1.14,1.49)。
  • 产业资助与发表概率轻度降低相关(OR=0.81;95%CI:0.67,0.99)。

关键数值与推荐

  • 有利结果与发表概率的关联:OR=2.04;95%CI:1.62,2.57。
  • 统计学显著结果与发表概率的关联:OR=2.07;95%CI:1.52,2.81。
  • 多中心设计与发表概率的关联:OR=1.32;95%CI:1.16,1.45。
  • 较晚监管分期(3/4期 vs. 1/2期)与发表概率的关联:OR=1.34;95%CI:1.14,1.49。
  • 产业资助与发表概率的关联:OR=0.81;95%CI:0.67,0.99。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: The aim of this study was to identify and quantify the characteristics of studies associated with the likelihood of publication. STUDY DESIGN AND SETTING: We searched for manuscripts that tracked cohorts of clinical studies ("cohorts") that from launch to publication. We explored the association of study characteristics with the probability of publication via traditional meta-analyses and meta-regression using random effects models. RESULTS: The literature review identified 85 cohorts of studies that met our inclusion criteria. The probability of publication was significantly higher for studies whose characteristics were favorable (odds ratio [OR] = 2.04; 95% confidence interval [CI]: 1.62, 2.57) or statistically significant (OR = 2.07; 95% CI: 1.52, 2.81), had a multicenter design (OR = 1.32; 95% CI: 1.16, 1.45), and were of later regulatory phase (3/4 vs. 1/2, OR = 1.34; 95% CI: 1.14, 1.49). Industry funding was modestly associated with lower (OR = 0.81; 95% CI: 0.67, 0.99) probability of publication. An exploratory analysis of effect modification revealed that the effect of the study characteristic "favorable results" on likelihood for publication was stronger for industry-funded studies. CONCLUSION: The study characteristics of favorable and significant results were associated with greater probability of publication.

来源:J Clin Epidemiol,查看原文。版权归原作者所有。

引用

  1. Canestaro WJ, Hendrix N, Bansal A, et al. Favorable and publicly funded studies are more likely to be published: a systematic review and meta-analysis. J Clin Epidemiol. 2017. PMID: 28842289. doi:10.1016/j.jclinepi.2017.08.004

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。